137 results on '"Yunoki, Mikihiro"'
Search Results
2. Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan
3. Successful removal of porcine circovirus-1 from immunoglobulin G formulated in glycine solution using nanofiltration
4. Changes in anti-SARS-CoV-2 antibody titers of pooled plasma derived from donors in Japan: a potential tool for mass-immunity evaluation
5. Decline in intravenous immunoglobulin titer against influenza virus A/H2N2 derived from donors in Japan
6. Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives
7. Long‐term monitoring of antibody titers against microorganisms in human intravenous immunoglobulin lots derived from healthy donors in Japan manufactured during 1998–2018
8. Caution in evaluation of removal of virus by filtration: Misinterpretation due to detection of viral genome fragments by PCR
9. Polyethyleneimine-modified resins effectively remove porcine circovirus and cellular prion protein
10. Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants
11. Screening for parvovirus B19 antigen through chemiluminescent enzyme immunoassay is equivalent to B19 nucleic acid amplification test‐based screening of pooled plasma
12. Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
13. Molecular detection of genotype 3 porcine hepatitis E virus in aborted fetuses and their sows
14. Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
15. Neutralizing and binding activities against SARS‐CoV ‐1/2, MERS‐CoV , and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan
16. Hepatitis A virus strain KRM238 resistant at heat inactivation
17. Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1
18. Long-Term Shedding of Hepatitis E Virus in the Feces of Pigs Infected Naturally, Born to Sows With and Without Maternal Antibodies†
19. Possible removal of prion agents from blood products during the manufacturing process
20. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobulin preparations
21. Hepatitis E virus in Norway rats (Rattus norvegicus) captured around a pig farm
22. Neutralizing and binding activities against SARS‐CoV‐1/2, MERS‐CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
23. Long-term monitoring of virus antibody titers in human intravenous immunoglobulin lots derived from donors in Japan
24. Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
25. Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
26. Distribution and Propagation of Hepatitis E Virus in Experimentally Infected Swine
27. Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus
28. Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
29. Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
30. Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010
31. Misinterpretation in virus clearance studies of biological products due to an uncommon discrepancy between cytopathic effects and infectivity of human immunodeficiency virus (HIV)
32. Development of Two Types of Rapid Diagnostic Test Kits To Detect the Hemagglutinin or Nucleoprotein of the Swine-Origin Pandemic Influenza A Virus H1N1
33. Full-Length Sequences of One Genotype 4 and Three Genotype 3 Hepatitis E Viruses in Fecal Samples from Domestic Swine in Japan
34. Infectious prion protein in the filtrate even after 15nm filtration
35. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition
36. Long‐term shedding of hepatitis E virus in the feces of pigs infected naturally, born to sows with and without maternal antibodies
37. Sequence Variation in Hepatitis E Virus Genotypes 3 and 4 from Swine Fecal Samples in Japan
38. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
39. No apparent difference in the prevalence of parvovirus B19 infection between chronic fatigue syndrome patients and healthy controls in Japan
40. 3P-252 Size diversity of parvovirus B19 and its behavior on the virus removal filter.(Bioimaging,The 47th Annual Meeting of the Biophysical Society of Japan)
41. Prion removal by nanofiltration under different experimental conditions
42. Distribution and Propagation of Hepatitis E Virus in Experimentally Infected Swine
43. Efficient detection of PrPSc (263K) in human plasma
44. Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus
45. Inactivation of HIV-1 during a fibrinogen manufacturing process.
46. Hepatitis C Virus More Resistant to Inactivation than Human Immunodeficiency Virus
47. Development of Human Monoclonal Antibodies Against Human Cytomegalovirus
48. Protective Role of Human Intravenous Immunoglobulin from Influenza A Virus Infection in Mice
49. Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010.
50. Efficient detection of PrPSc (263K) in human plasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.